This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ sulfisoxazole (antibiotic)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Antibacterial Activity: Sulfisoxazole works by inhibiting the growth and reproduction of bacteria. It achieves this by interfering with the synthesis of folic acid, which is essential for bacterial DNA and protein production. By inhibiting the enzyme dihydropteroate synthase, sulfisoxazole prevents the conversion of p-aminobenzoic acid (PABA) to dihydropteroic acid, a crucial step in folic acid synthesis in bacteria.

  2. Treatment of Bacterial Infections: Sulfisoxazole is used to treat a variety of bacterial infections, including urinary tract infections (UTIs), respiratory tract infections, gastrointestinal infections, and certain types of skin infections. It is effective against a wide range of gram-positive and gram-negative bacteria, including Escherichia coli, Streptococcus pyogenes, and Staphylococcus aureus.

  3. Combination Therapy: Sulfisoxazole is often combined with other antibiotics, such as trimethoprim, to create synergistic effects. This combination is known as sulfamethoxazole-trimethoprim (co-trimoxazole or TMP-SMX) and is commonly used to treat urinary tract infections, respiratory infections, and other bacterial infections.

  4. Side Effects: Like other sulfonamide antibiotics, sulfisoxazole can cause various side effects, including nausea, vomiting, diarrhea, allergic reactions (such as skin rash and itching), photosensitivity (increased sensitivity to sunlight), and hematological abnormalities (such as leukopenia and hemolytic anemia). Rare but serious adverse effects may include Stevens-Johnson syndrome and toxic epidermal necrolysis.

  5. Drug Interactions: Sulfisoxazole may interact with other medications, including oral anticoagulants (e.g., warfarin), oral hypoglycemic agents (e.g., sulfonylureas), and certain diuretics (e.g., thiazides). These interactions can affect the metabolism and efficacy of co-administered drugs and may require dosage adjustments or close monitoring.

  6. Resistance: Prolonged or indiscriminate use of sulfisoxazole and other antibiotics can contribute to the development of bacterial resistance. It is essential to use sulfisoxazole judiciously and according to prescribed guidelines to minimize the emergence of resistant bacterial strains.

  7. Medical Supervision: Sulfisoxazole should be used under the guidance and supervision of a qualified healthcare professional. Patients should follow the prescribed dosage and duration of treatment, even if their symptoms improve before completing the course of antibiotics.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of sulfisoxazole (antibiotic) On Probiotics

Bacteria Impacted by sulfisoxazole (antibiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of sulfisoxazole (antibiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]